In this episode we continue our journey looking at the innate immune system and focus on some important immune cells called natural killer (NK) cells and their potential in cancer immunotherapy. You'll hear from both academic and industry experts who are active in research in this field, including Dr Todd Fehniger (Washington University in St Louis), Dr Michael Caligiuri (City of Hope), Dr Jeff Miller (Minnesota), Prof Eric Vivier (Innate Pharma via Marseille Immunopole), Dr Nick Huntington (Walter & Eliza Hall Institute in Melbourne), Dr James Gulley (NCI), and Dr Deepak Sampath (Genentech). Some important topics we will cover: - What are NK cells? - What do the do? - How do they 'see'? - How can they be boosted? - What kind of approaches have been developed therapeutically? - What kind of clinical data have we seen so far? - What's the vision for the future of NK cell therapy development? You can find more detailed information about the topics discussed in the show notes on https://noveltargets.com. These interviews were conducted in various cities around the world or at AACR, ASCO, ASH, BMT Tandem and CIMT meetings between 2016 to 2018. Full transcripts of the individual interviews can be found on https://biotechstrategyblog.com (subscription required). The music is by violinist and composer David Schulman. Listen to more at http://www.quietlifemotel.com. © 2018 Blue Ice Publishing LLC. All Rights Reserved